Post Graduate Institute of Medical Education and Research, Chandigarh: Liver Cirrhosis trials

The registry lists 21 Liver Cirrhosis studies with Post Graduate Institute of Medical Education and Research, Chandigarh as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 2 5Phase 3 6Phase 4 2No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol SepsisRecruitingNCT07286643Not applicable
• BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HERecruitingNCT06538077Phase 4
• Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and SurvivalRecruitingNCT06431919Not applicable
• Cirrhotic Cardiomyopathy Based on Point-of-care Echocardiography, Biomarkers and HistologyRecruitingNCT06095466
• Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Refractory AscitesRecruitingNCT05700708
• Ivabradine in Cirrhotic CardiomyopathyRecruitingNCT04111133Not applicable
• 20% Albumin vs. Balanced Salt Solution as Resuscitation Fluid in Cirrhosis With Sepsis Induced HypotensionStatus unknownNCT05441878Phase 4
• Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Hepatorenal Syndrome-Acute Kidney InjuryStatus unknownNCT05434286
• Growth Hormone in Decompensated Liver CirrhosisCompletedNCT05253287Phase 2/3
• Goal-Directed Hemostatic Resuscitation Trial in ACLF Induced CoagulopathyCompletedNCT05124041Not applicable
• Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver DiseaseCompletedNCT05107271
• Volume Resuscitation in Cirrhosis With Sepsis Induced HypotensionCompletedNCT05059795
• Fecal Microbiota Transplantation in Decompensated CirrhosisCompletedNCT04842539Not applicable
• Global Coagulation Assessment in Cirrhosis and ACLFCompletedNCT04332484
• Periodontal Therapy and Oral-gut-hepatic Axis Cirrhosis: a Randomized Controlled TrialStatus unknownNCT04330469Not applicable
• Heparin Like Effect in Acute Variceal BleedingStatus unknownNCT04111120
• GCSF Therapy in Decompensated Cirrhosis - A Double Blinded RCTStatus unknownNCT03911037Phase 2/3
• Rifaximin and Norfloxacin for Prevention of SBP in Adults With Decompensated CirrhosisCompletedNCT03695705Phase 3
• Growth Hormone Therapy in Liver CirrhosisCompletedNCT03420144Phase 2/3
• G-CSF in Decompensated Cirrhosis: an Open Label TrialStatus unknownNCT03415698Phase 2/3
• Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent AscitesCompletedNCT02173288Phase 2/3